etelcalcetide
Selected indexed studies
- Etelcalcetide. (, 2006) [PMID:37603680]
- Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. (JAMA, 2017) [PMID:28097356]
- Etelcalcetide: What we know eight years since its approval. (Nefrologia (Engl Ed), 2025) [PMID:39986712]
_Worker-drafted node — pending editorial review._
Connections
etelcalcetide is a side effect of
Sources
- Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. (2017) pubmed
- Impact of Cinacalcet and Etelcalcetide on Bone Mineral and Cardiovascular Disease in Dialysis Patients. (2023) pubmed
- Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ? (2018) pubmed
- Etelcalcetide. (2006) pubmed
- Etelcalcetide: What we know eight years since its approval. (2025) pubmed
- Etelcalcetide: First Global Approval. (2016) pubmed
- Etelcalcetide for the treatment of secondary hyperparathyroidism. (2017) pubmed
- Etelcalcetide versus placebo for secondary hyperparathyroidism in patients receiving hemodialysis: A meta-analysis of randomized controlled trials. (2020) pubmed
- Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal. (2018) pubmed
- Formulary Drug Review: Etelcalcetide. (2017) pubmed